COPPER Publications, 2011-Present – Sorted by Cancer Type

Sort by Topic

Names of COPPER members appear in bold

Breast Cancer

Fox JP, Zikmund-Fisher BJ, Gross CP. Older patient experiences in the mammography decision-making process. Arch Int Med. 2012;172(1):62-4. PMID22232149.

Soulos PRYu JBRoberts KBRaldow ACHerrin JLong JBGross CP. Assessing the impact of a cooperative group trial on breast cancer care in the Medicare population. J Clin Oncol. 2012;30(14):1601-7. PMID22393088.

Presley CJ, Soulos PR, Herrin J, Roberts KB, Yu JB, Killelea B,Lesnikoski B, Long JB, Gross CP. Patterns of use and short-term complications of breast brachytherapy in the national Medicare population in 2008-2009. J Clin Oncol. 2012;30(35):4302-7. PMID23091103.

Chen JLong JB, Hurria A, Owusu C, Steingart RM, Gross CP. Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer. J Am Coll Cardiol. 2012;60(24):2504-12. PMID23158536.

Feinstein AJ, Soulos PRLong JBHerrin JRoberts KBYu JBGross CP. Variation in Receipt of Radiation Therapy after Breast-Conserving Surgery: Assessing the Impact of Physicians and Geographic Regions. Med Care. 2012;51(4):330-338. PMID23151590.

Roberts KBSoulos PRHerrin JYu  JBLong JB, Dostaler E, Gross CP.  The Adoption of New Adjuvant Radiotherapy Modalities among Medicare Beneficiaries with Breast Cancer:  Clinical Correlates and Cost Implications. Int J Radiat Oncol Biol Phys. 2012;85(5):1186-92. PMID23182396.

Gross CPLong JBRoss JS, Abu-Khalaf M, Wang RKillelea BK, Gold HT, Chagpar ABMa X. The Cost of Breast Cancer Screening in the Medicare Population. JAMA Intern Med. 2013;173(3):220-6. PMID23303200.

Killelea BK, Long JB, Chagpar AB, Ma X, Soulos PR, Ross JS, Gross CP. Trends and Clinical Implications of Preoperative Breast MRI in Medicare Beneficiaries with Breast Cancer. Breast Cancer Res Treat. 2013;141(1):155-63. PMID23942872.  

Ezaz G, Long JB, Gross CP, Chen J. Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. J Am Heart Assoc. 2014;3(1):e000472. PMID24584736.

Killelea BK, Gross CP. Is the use of preoperative breast MRI resulting in more invasive breast cancer surgery? Women's Health (Lond Engl). 2014;10(1)1-3. PMID24328592.

Elmore JG, Gross CP. The Cost of Breast Cancer Screening in the United States: A Picture Is Worth... a Billion Dollars? Ann Intern Med. 2014;160(3):203-204-204.

Sen S, Wang SY, Soulos PR, Frick KD, Long JB, Roberts KB, Yu JB, Evans SB, Chagpar AB, Gross CP. Examining the Cost-Effectiveness of Radiation Therapy Among Older Women With Favorable-Risk Breast Cancer. J Natl Cancer Inst. 2014;106(3):dju008. PMID24598714.

Sen S, Soulos PR, Herrin J, Roberts KB, Yu JB, Lesnikoski B, Ross JS, Krumholz HM, Gross CP. For-Profit Hospital Ownership Status and Use of Brachytherapy after Breast-Conserving Surgery. Surgery. 2014;155(5):776-88. PMID24787104.

Prostate Cancer

Makarov DVYu JB, Desai RA, Penson DF, Gross CP. The association between diffusion of the surgical robot and radical prostatectomy rates. Med Care. 2011;49(4):333-9. PMID21368677.

Yu JBMakarov DVGross C. A new formula for prostate cancer lymph node risk. Int J Radiat Oncol Biol Phys. 2011;80(1):69-75. PMID20594769.

Makarov DV, Desai RA, Yu JB, Sharma R, Abraham N, Albertsen PC, Person DF, Gross CP. The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the Medicare population. J Urol. 2012;187(1):97-102. PMID22088337.

Raldow ACPresley CJYu JB, Sharma R, Cramer LDSoulos PRLong JBMakarov DVGross CP. The relationship between clinical benefit and receipt of curative therapy for prostate cancer. Arch Intern Med. 2012;172(4):362-3. PMID22371925.

Makarov DV, Desai RA, Yu JB, Sharma R, Abraham N, Albertsen PC, Krumholz HM, Penson DF, Gross CP.Appropriate and inappropriate imaging rates for prostate cancer go hand in hand by region, as if set by thermostat. Health Aff. 2012;31(4):730-40. PMID22492890.

Ross JS, Wang R, Long JB, Gross CP, Ma X. Impact of the 2008 US Preventive Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries. Arch Intern Med. 2012;172(2):1601-3. PMID22987029.

Quon JL, Yu JB, Soulos PR, Gross CP. The relation between age and androgen deprivation therapy use among men in the Medicare population receiving radiation therapy for prostate cancer. J Geriatric Oncol. 2012;4(1):9-18. PMID23482846.

Yu JBSoulos PRHerrin JCramer LD, Potosky AL, Roberts KBGross CP. Proton versus intensity-modulated radiotherapy for prostate cancer:  Patterns of care and early toxicity. J Natl Cancer Inst. 2013;105(1):25-32. PMID23243199.

Presley CJRaldow ACCramer LDSoulos PRLong JBYu JBMakarov DVGross CP. A New Approach to Understanding Racial Disparities in Prostate Cancer Treatment. J Getriatric Oncol. 2013;4(1):1-8. PMID23828723.

Ma X, Wang R, Long JB, Ross JS, Soulos PR, Yu JB, Makarov DV, Gold HT, Gross CP. The Cost Implications of Prostate Cancer Screening in the Medicare Population. Cancer. 2013;120(1):96-102. PMID24122801.

Kim SP, Karnes RJ, Nguyen PL, Ziegenfuss JY, Thompson RH, Han LC, Shah ND, Smaldone MC, Gross CP, Frank I, Weight CJ, Beebe TJ, Tilburt JC. A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer. BJU Int. 2013. PMID24053213

Kim SP, Tilburt JC, Karnes RJ, Ziegenfuss JY, Han LC, Shah ND, Frank I, Smaldone MC, Gross CP, Yu JB, Trinh QD, Sun M, O'Malley RL, Nguyen PL. Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty. Urology. 2013;82(4):807-12.  PMID23910088.

Aneja S, Yu JB. Comparative effectiveness research in radiation oncology: stereotactic radiosurgery, hypofractionation, and brachytherapy. Semin Radiat Oncol. 2014;24(1):35-42. PMID24314340.

Yu JB, Cramer LD, Herrin J, Soulos PR, Potosky AL, Gross CP. Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy for Prostate Cancer: Comparison of Toxicity. J Clin Oncol. 2014;32(12)1195-201. PMID24616315.

Lung Cancer

Park HSDetterbeck FC, Boffa DJ, Kim AW. Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomes. Ann Thorac Surg. 2012;93(2):372-9. PMID21945225.

Vest M, Tanoue TSoulos PRKim AWDetterbeck FMorgensztern D, Gross CP. Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancer. J Thorac Oncol. 2012;7(1):188-95 PMID22134069.

Kim AW, Detterbeck FC, Boffa DJ, Decker RHSoulos PRCramer LDGross CP. Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer. Ann Thorac Surg. 2012;94(3):895-901. PMID22835558.

Vest MTHerrin JSoulos PRDecker RH, Tanoue L, Michaud G, Kim AW, Detterbeck F, Morgensztern D, Gross CP. Use of New Treatment Modalities for Non-Small Cell Lung Cancer Care in the Medicare Population. Chest. 2012;143(2):429-435. PMID23187634.

Moreno AC, Morgensztern D, Boffa DJ, Decker RH, Yu JB, Detterbeck FC, Wang Z, Rose MG, Kim AW. Treating Locally Advanced Disease: An Analysis of Very Large, Hilar Lymph Node Positive Non-Small Cell Lung Cancer Using the National Cancer Data Base. Ann Thorac Surg. 2014;97(4):1149-55 PMID24582051

Colorectal Cancer

Fox JGross CP, Longo W, Reddy V. Laparoscopic colectomy for the treatment of cancer has been widely adopted in the United States. Dis Colon Rectum. 2012;55(5):501-8. PMID22513427.

Gross CPSoulos PRRoss JSCramer LD, Guerrero C, Tinetti ME, Braithwaite RS. Assessing the impact of screening colonoscopy on mortality in the Medicare population. J Gen Intern Med. 2011;26(12):1441-9. PMID21842323.

Khiani VS, Soulos P, Gancayco J, Gross CP. Anesthesiologist involvement in screening colonoscopy: Temporal trends and cost implications in the Medicare population. Clin Gastroenterol Hepatol. 2012;10(1):58-64. PMID21782768.

Fox JP, Desai MM, Krumholz HM, Gross CP. Hospital-level outcomes associated with laparoscopic colectomy for cancer in the minimally invasive era. J Gastrointest Surg. 2012;16(11):2112-9. PMID22948842.

Gancayco J, Soulos PR, Khiani V, Cramer LD, Ross JS, Genao I, Tinetti M, Gross CP. Age and Sex-Based Disparities in Screening Colonoscopy Use Among Medicare Beneficiaries. J Clin Gastroenterol. 2013;47(7):630-6. PMID23619827.  

Hematological Malignancies

Wang R, Gross CP, Maggiore RJ, Halene SSoulos PR, Raza A, Galili N, Ma X. Pattern of hypomethylating agents use among elderly patients with myelodysplastic syndromes. Leuk Res. 2011;35(7):904-8. PMID21067809.

Wang RGross CP, Frick K, Xu XLong J, Raza A, Galili N, Zikria J, Guan Y, Ma X. The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes. Leuk Res. 2012;36(11):1370-5. PMID22917770.

Nath SK, Yu JB, Wilson LD. Poorer Prognosis of African-American Patients With Mycosis Fungoides: An Analysis of the SEER Dataset, 1988 to 2008. Clin Lymphoma Myeloma Leuk. 2014;Epub ahead of print. PMID24508350.

Nonmelanoma Skin Cancer

Viola KV, Jhaveri MB, Soulos PR, Turner RB, Tolpinrud WL, Doshi D, Gross CP. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population. Arch Dermatol. 2012;148(4):473-7. PMID22508870.

Head and Neck Cancer

Yu JBSoulos PR, Sharma R, Makarov DVDecker RH, Smith BD, Desai RA, Cramer LDGross CP. Patterns of care and outcomes associated with intensity modulated radiation therapy versus conventional radiation therapy for older patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2012;83(1):e101-7. PMID22342095.

Non-Cancer Specific

Aneja SGross CPSoulos PRYu JB. Geographical Information Systems: Applications and limitations in oncology research. Oncology. 2011;25(12):1221-5. PMID22229219.

Aneja S, Smith BD, Gross CPWilson LD, Haffty BG, Roberts KBYu JB. A geographic analysis of the radiation oncology workforce. Int J Radiat Oncol Biol Phys. 2012;82(5):1723-9. PMID21493013.

Ross JS, Lehman R, Gross CP. The importance of clinical trial data sharing: toward more open science. Circ Cardiovasc Qual Outcomes. 2012;5(2):238-40. PMID22438465.

Park HSMakarov DGross CPYu B. Immortal time bias: A frequently unrecognized threat to validity in the evaluation of postoperative radiation therapy. Int J Radiat Oncol Biol Phys. 2012;83(5):1365-73 PMID22342097.

Lloyd S, Buscariollo DL, Gross CP, Makarov DV, Yu JB. Determinants of enrollment in cancer clinical trials: the relationship between the current state  of knowledge, societal disease burden, and randomized clinical trial enrollment.  J Natl Compr Canc Netw. 2013 Aug;11(8):928-36. PMID23946172.

Lloyd S, Dosoretz AP, Yu JB, Evans SB, Decker RH. Academic and Resident Radiation Oncologists' Attitudes and Intentions Regarding Radiation Therapy near the End of Life. Am J Clin Oncol. 2014;Epub ahead of print. PMID24390273.